SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150

Saved in:
Bibliographic Details
Published inJoint, bone, spine : revue du rhumatisme Vol. 89; no. 1; p. 105282
Main Authors Cadiou, Simon, Perdriger, Aleth, Ardois, Samuel, Albert, Jean-David, Berthoud, Olivia, Lescoat, Alain, Guggenbuhl, Pascal, Robin, François
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.01.2022
Published by Elsevier Masson SAS on behalf of Société française de rhumatologie
Subjects
Correspondence
COVID-19
COVID-19 Vaccines
Giant Cell Arteritis
Humans
Polymyalgia Rheumatica
Recurrence
SARS-CoV-2
Vaccine
COVID-19
SARS-CoV-2
Vaccine
Giant cell arteritis
Polymyalgia rheumatica
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:1297-319X
1778-7254
DOI:10.1016/j.jbspin.2021.105282